Researchers at MIT have just developed a new lipid nanoparticle that super-enhances the effectiveness of the mRNA vaccine in ...
RNA-based therapeutics are transforming medicine, but scaling production efficiently remains a challenge, particularly the ...
A new delivery particle developed at MIT could make mRNA vaccines more effective and potentially lower the cost per vaccine ...
A research team led by Cancer Center at Illinois (CCIL) member Hua Wang has published new research detailing a new mRNA cancer vaccine platform. The study introduces an immune cell homing ...
Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have ...
BIOVECTRA, a part of Agilent Technologies Inc., and Revolution Biomanufacturing Inc. today announced a collaboration that grants BIOVECTRA access to Revolution Biomanufacturing's proprietary platforms ...
This video shows the process of learning 2D animation in a short period. It includes rough sketches, keyframe planning, and coloring stages, highlighting the time and effort required in frame-by-frame ...
Biovectra and Revolution Biomanufacturing have announced a collaboration that grants Biovectra access to Revolution Biomanufacturing's proprietary platforms to enhance mRNA stability and translational ...
NEW YORK - Applied DNA Sciences, Inc. (NASDAQ:APDN), currently trading at $4.27 and showing a -98% return over the past year according to InvestingPro data, announced Monday it will change its ticker ...